Are HMG-CoA reductase inhibitors cost effective?

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 1997年 / 9卷 / 9期
关键词：
D O I：
10.2165/00042310-199709090-00003
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：14 / 16
页数：2
相关论文
共 50 条
  • [41] Pleiotropic effects of HMG-CoA reductase inhibitors
    Nikos Werner
    Georg Nickenig
    Ulrich Laufs
    Basic Research in Cardiology, 2002, 97 : 105 - 116
  • [42] HMG-CoA reductase inhibitors in atherosclerosis.
    Buckley, BM
    INSULIN RESISTANCE, METABOLIC DISEASES AND DIABETIC COMPLICATIONS, 1999, 1177 : 219 - 224
  • [43] BIOCHEMISTRY AND PHARMACOLOGY OF HMG-COA REDUCTASE INHIBITORS
    ENDO, A
    ATHEROSCLEROSIS VIII, 1989, 817 : 775 - 780
  • [44] Pleiotropic effects of HMG-CoA reductase inhibitors
    Werner, N
    Nickenig, G
    Laufs, U
    BASIC RESEARCH IN CARDIOLOGY, 2002, 97 (02) : 105 - 116
  • [45] Comparative Tolerability of the HMG-CoA Reductase Inhibitors
    John A. Farmer
    Guillermo Torre-Amione
    Drug Safety, 2000, 23 : 197 - 213
  • [46] HMG-COA REDUCTASE INHIBITORS, GEMFIBROZIL, AND MYOPATHY
    TOBERT, JA
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (12): : 862 - 862
  • [47] Pleiotropic effects of the HMG-CoA reductase inhibitors
    Mihos, Christos G.
    Santana, Orlando
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2011, 4 : 261 - 271
  • [48] HMG-COA REDUCTASE INHIBITORS AND SLEEP - REPLY
    VGONTZAS, AN
    KALES, A
    BIXLER, EO
    MANFREDI, RL
    TYSON, KL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (01) : 110 - 111
  • [49] More on comparison of HMG-CoA reductase inhibitors
    Hsu, I
    Spinler, SA
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (04) : 414 - 415
  • [50] HMG-CoA reductase inhibitors and the risk of fractures
    Meier, CR
    Schlienger, RG
    Kraenzlin, ME
    Schlegel, B
    Jick, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (24): : 3205 - 3210
12345